Diabetes in the Middle East and North Africa

Abstract Aims Even though the Middle East and North Africa (MENA) region had the highest comparative prevalence of diabetes in 2012, little is known about the nuances of diabetes risk and capacity to address the burdens. To provide a comprehensive overview, we reviewed the literature on diabetes in...

Full description

Saved in:
Bibliographic Details
Published in:Diabetes research and clinical practice 2013-08, Vol.101 (2), p.106-122
Main Authors: Zabetian, Azadeh, Keli, Heval Mohamed, Echouffo-Tcheugui, Justin B, Narayan, K.M. Venkat, Ali, Mohammed K
Format: Article
Language:English
Subjects:
Africa, Northern - epidemiology
Diabetes Mellitus, Type 2 - epidemiology
Endocrinology & Metabolism
Epidemiology
Humans
Middle East - epidemiology
Middle East and North Africa
Type 2 diabetes mellitus
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Aims Even though the Middle East and North Africa (MENA) region had the highest comparative prevalence of diabetes in 2012, little is known about the nuances of diabetes risk and capacity to address the burdens. To provide a comprehensive overview, we reviewed the literature on diabetes in the MENA region. Methods We conducted a systematic search in PubMed between January 1990 and January 2012 for studies on diabetes in the MENA region without language restriction. Results There was a paucity of country-specific epidemiology data in the region. Diabetes prevalence varied widely across studies, from 2.5% in 1982 to 31.6% in 2011. Older age and higher body mass index were the most strongly associated risk factors for diabetes. Among people with diabetes, over half did not meet recommended care targets. In addition, macrovascular and microvascular complications were observed in 9–12% and 15–54% of diabetes population, respectively. Conclusions This review suggests a need for more representative surveillance data in this noteworthy focal point of the global diabetes epidemic. Such actions will not only help to understand the actual burden of diabetes but also motivate actions on design and implementation of diabetes prevention and control programs.
ISSN:0168-8227
1872-8227
DOI:10.1016/j.diabres.2013.03.010